Paul Hastings advised Spectrum Pharmaceuticals, Inc. on the deal
Spectrum Pharmaceuticals, Inc. executed the sale of seven FDA-approved hematology/oncology products to Acrotech Biopharma LLC, a subsidiary of Aurobindo Pharma USA, Inc., for up to $300 million.
Spectrum Pharmaceuticals, Inc. is a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology. The company, led by Joseph W Turgeon, Francois Lebel and Kurt A Gustafson, in 2018 recorded $109 Million Revenues.
Corporate Partner Carl R. Sanchez (Picture) in San Diego led the Paul Hastings team, which also included associates Spencer Young, Tyler Dodge and Philip Dodd.
Law Firms: Paul Hastings;
Clients: Spectrum Pharmaceuticals Inc.;